Correlation of Perioperative Brain Metabolites With Postoperative Delirium in Elderly Oral Craniomaxillofacial Surgery Patients
1 other identifier
observational
46
1 country
1
Brief Summary
In view of the increasingly severe aging situation in China, the perioperative brain health of elderly patients has received increasing attention. Postoperative delirium (POD) is a common postoperative complication characterized by acute consciousness and cognitive dysfunction. The incidence of POD in elderly patients undergoing elective non cardiac surgery is 20%\~45%, which often indicates poor cognitive recovery and becomes a heavy burden for family and society. Although the weight of human brain only accounts for 2% of body weight, the oxygen consumption accounts for 20% of the total oxygen consumption of the whole body. On July 2, 2022, the British Journal of Anaesthesia (Chinese Academy of Sciences Division 1, Anesthesiology Division 1, IF11.719), the top international Journal in the field of anesthesiology, published the scientific research achievements of the first author of the applicant. It was found for the first time that sevoflurane, the most commonly used inhalation anesthetic in clinical practice, can cause the activation of glycolysis and the increase of lactic acid in the brain of elderly non-human primate marmosets, which suggests that general anesthetics will affect brain metabolism in the perioperative period. Therefore, we hypothesized that perioperative changes in brain metabolism might be related to the occurrence of POD in elderly patients. The purpose of this study was to study the relationship between the changes of brain metabolites and POD during perioperative period by noninvasive monitoring of the characteristics of brain tissue metabolites 24 hours before and 24 hours after the operation with hydrogen ion proton magnetic resonance spectroscopy (1-HMRS). In order to complete this purpose, this study plans to collect subjects aged 65\~90 years who are scheduled to undergo oral and maxillofacial surgery under general anesthesia. The changes of brain metabolites before and after operation were collected by 1-HMRS, and the postoperative delirium related scale was evaluated to analyze the relationship between perioperative changes of brain metabolites and POD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 18, 2022
CompletedFirst Submitted
Initial submission to the registry
January 12, 2023
CompletedFirst Posted
Study publicly available on registry
January 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 6, 2023
November 1, 2022
3 years
January 12, 2023
July 3, 2023
Conditions
Outcome Measures
Primary Outcomes (7)
3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale
3D-CAM higher means worse
1 day after surgery
3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale
3D-CAM higher means worse
2 day after surgery
3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale
3D-CAM higher means worse
3 day after surgery
3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale
3D-CAM higher means worse
4 day after surgery
3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale
3D-CAM higher means worse
5 day after surgery
3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale
3D-CAM higher means worse
6 day after surgery
3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale
3D-CAM higher means worse
7 day after surgery
Secondary Outcomes (6)
MOCA(Montreal Cognitive Assessment) scale
1 day after surgery
MOCA(Montreal Cognitive Assessment) scale
3 day after surgery
MOCA(Montreal Cognitive Assessment) scale
7 day after surgery
MMSE (mini-mental state examiniation) scale
1 day after surgery
MMSE (mini-mental state examiniation) scale
3 day after surgery
- +1 more secondary outcomes
Study Arms (2)
Patients in the control group were followed up without delirium postoperatively.
If the 3D-CAM scale all show a negative resluts
Patients in the case group were followed up with delirium postoperatively.
If the 3D-CAM assessment is positive at any time point after surgery
Interventions
Collecting clinical data(before induction of anesthesia and first day after surgery), blood gas data(before induction of anesthesia and first day after surgery) ,MRS data (not more than 24h after surgery)and blood,urine, and feces sample (before induction of anesthesia and first day, third day and 7th day after surgery)
Eligibility Criteria
Our research is a single center, nested case-control study. Preoperatively collect the information of the elderly patients 65-90 years old without undergoing craniocerebral operations, including the vital signs, the examination reports and other related data after excluding the factors that can't be included in the group. The patients' health scales and delirium scales were evaluated.
You may qualify if:
- The ASA grade of the subject is Ⅰ - Ⅲ;
- years old;
- Oral craniomaxillofacial surgery under combined general anesthesia
You may not qualify if:
- The following medical devices have been installed in the body or are to be installed or implanted in the hospital: various cardiac pacemakers; Metal implants (non titanium), ferromagnetic vascular clips in the body
- The patient is left-handed;
- Patients with claustrophobia;
- People with vision and hearing impairment, illiterate or difficult to communicate;
- The operation plan includes patients with tracheotomy or postoperative catheterization;
- Refusing to sign the clinical trial consent form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai 9Th Hospital
Shanghai, Shanghai Municipality, 200000, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hong Jiang, Doctor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2023
First Posted
January 23, 2023
Study Start
November 18, 2022
Primary Completion
December 1, 2025
Study Completion
December 31, 2025
Last Updated
July 6, 2023
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share